Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Power3 Medical Products Inc. CEO Interview: Helen R. Park

Dr. Stock Pick (September 16th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_______________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_______________________________________

Wednesday September 16, 2009

DrStockPick.com Stock Report!

**************************************************************

Power3 Medical Products Inc. CEO Interview: Helen R. Park

67 WALL STREET, New York - September 15, 2009 - The Wall Street Transcript has just published its Medical Research Services report offering a timely review of the sector to serious investors and industry executives. This 23 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Topics covered: Medical Device Research Services - Pharmaceutical Research Services - Diagnostics - Life Science Research Supplies

...
Tags for this Post:
(212) 952-7433, (281) 466-1600 (281), 466-1600 (281) 466-1481, 67 WALL, 800/246-7673, Advanced Bio/Chem Inc., ALS, Amgen, arrowhead research, Beckman Coulter, Breast Cancer, Bristol Myers, broker, ceo, Cfo, Cleveland BioLabs, Critical Care Systems Inc., Crown Equity Holdings Inc.;, Danaher;, diagnostic tests, Dow Chemical, Dr Stock Pick, Eli Lilly & Co, Fda, general disease, Greece, Helen R. Park CEO, Helen R. Park;, Illumina;, imaging, interview, Invitrogen, IR BioSciences Holdings, Labcorp, Life Science Research Supplies, Life Technologies;, Luminex, Ms. Park, neurodegenerative disease;, New York, Power3 Medical Products Inc.;, QIAGEN, Sangamo BioSciences, Sigma-Aldrich;, stock featured on our site;, Stocks to Watch, Texas, This technology;, United States, USD, Waters, www.power3medical.com

Power3 Medical Products Inc. CEO Interview: Helen R. Park

stock-pr (September 15th, 2009) Writes:

6Power3 Medical Products Inc. CEO Interview: Helen R. Park7 WALL STREET, New York - September 15, 2009 - The Wall Street Transcript has just published its Medical Research Services report offering a timely review of the sector to serious investors and industry executives. This 23 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Topics covered: Medical Device Research Services - Pharmaceutical Research Services - Diagnostics - Life Science Research Supplies - Biology R & D - Lab Services Business Model - International Economic Exposure - Effect of Recession on Sector Stocks - Top Stock Winners and Losers in Medical Research Services - Top Stock Winners and Losers in Medical Diagnostics

Companies include: Arrowhead Research (ARWR); Cleveland BioLabs (CBLI); IR BioSciences Holdings (IRBS); Power3 Medical Products (PWRM);

...
Tags for this Post:
(212) 952-7433, (281) 466-1600 (281), 466-1600 (281) 466-1481, 6Power3 Medical Products Inc., 800/246-7673, Advanced Bio/Chem Inc., ALS, Amgen, arrowhead research, Beckman Coulter, Breast Cancer, Bristol Myers, ceo, Cfo, Cleveland BioLabs, Critical Care Systems Inc., Danaher;, diagnostic tests, Dow Chemical, Eli Lilly & Co, Fda, general disease, Greece, Helen R. Park CEO, Helen R. Park7 WALL STREET, Helen R. Park;, Illumina;, imaging, interview, Invitrogen, IR BioSciences Holdings, Labcorp, Life Science Research Supplies, Life Technologies;, Luminex, Medical Research Services, Ms. Park, neurodegenerative disease;, New York, Power3 Medical Products, QIAGEN, Sangamo BioSciences, Sigma-Aldrich;, Small & Micro Cap, Stock-PR, Texas, This technology;, United States, USD, Waters, www.power3medical.com

PWRM, Power3 Medical Products, Inc. Files for 3 Patents on Blood Test for Diagnosis of Early Stage Breast Cancer

Dr. Stock Pick (September 2nd, 2009) Writes:

PWRM, Power 3 Medical Products Inc, PWRM.OB

drstock

Dr Stock Pick HOT News & Alerts!

Power3 Medical Products, Inc. Files for 3 Patents on Blood Test

for Diagnosis of Early Stage Breast Cancer

signup3m

 

Wednesday September 2nd, 2009

************************************************************** Power3 Medical Products, Inc. Files for 3 Patents on Blood Test for Diagnosis of Early Stage Breast Cancer

Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), announced recently that the company made significant advances in the technology for their BC-SeraPro™ serum protein based blood test for diagnosis of early stage breast cancer, as disclosed in recent filings of three pending US utility patent applications.

“Roughly 200,000 women in the US and 1.2

...

Three Valuable Patents, Potential FDA Filing (OTC:PWRM)

Michael Vlaicu (September 1st, 2009) Writes:

Power3 Medical Products, Inc.

(Public, OTC:PWRM)

The following company analysis has been contributed by a StocksHaven Investments affiliate and member, Michael Sklar. He has been studying the markets for several years now with a focus in undiscovered Bio-Pharm companies.

About

Power3 Medical Products, Inc. (Power3) is primarily engaged in commercializing its intellectual properties in the area of diagnosis and treatment of breast cancer, Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s disease and Parkinson’s disease. In the area of neurodegenerative diseases and breast cancer, Power3 has completed research and clinical validation studies involving over 1,500 patient samples. Power3 uses biostatistical analysis to monitor appropriate panels of biomarkers for diagnostic sensitivity and specificity for disease, normal and disease controls. By testing patient body fluids and tissues, including blood serum (for breast cancer and neurodegenerative diseases), and bone marrow aspirates (for leukemia patients), the Company

...
Tags for this Post:
actual disease, Alan B. Hollingsworth, ALS, Alzheimer, amyotrophic lateral sclerosis, antibodies, Arizona, author, Banner Sun Health Research Institute, BC-SeraPro, Breast Cancer, cancer, Cancers, ceo, China, collector, diagnostic tests, Director of Breast MRI, ductal carcinoma in situ, Fda, Gemologist, Helen R. Park;, Ira L. Goldknopf, leukemia, Lung Cancer, Marwan Sabbagh, Maryland, Medical Director, member, Mercy Cancer, Mercy Cancer Resource Center, Mercy Women’s Center, Michael Sklar, Michael Vlaicu;, Mri, neurodegenerative disease;, neurodegenerative diseases, neurological disorders, NuroPro® AD, Oklahoma LLC, Ph.D., pharmaceutical and diagnostic, potential medical applications, Power3 Medical Products Inc.;, Power3;, President and Chief Scientific Officer, proteomics, Stocks to Watch, StocksHaven Investments;, Sun City, the Medical Director of Breast MRI, treatment of breast cancer, tumors, U.S. Food and Drug Administration, United States, USD

PWRM, Power3 Medical Products, Inc. Files for 3 Patents on Blood Test for Diagnosis of Early Stage Breast Cancer

Dr. Stock Pick (September 1st, 2009) Writes:

PWRM, Power 3 Medical Products Inc, PWRM.OB

drstock

Dr Stock Pick HOT News & Alerts!

Power3 Medical Products, Inc. Files for 3 Patents on Blood Test

for Diagnosis of Early Stage Breast Cancer

signup3m

 

Tuesday September 1st, 2009

************************************************************** Power3 Medical Products, Inc. Files for 3 Patents on Blood Test for Diagnosis of Early Stage Breast Cancer

Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), announced recently that the company made significant advances in the technology for their BC-SeraPro™ serum protein based blood test for diagnosis of early stage breast cancer, as disclosed in recent filings of three pending US utility patent applications.

“Roughly 200,000 women in the US and 1.2 million

...

PWRM, Power3 Medical Products, Inc. Files for 3 Patents on Blood Test for Diagnosis of Early Stage Breast Cancer

Dr. Stock Pick (August 31st, 2009) Writes:

PWRM, Power 3 Medical Products Inc, PWRM.OB

drstock

Dr Stock Pick HOT News & Alerts!

Power3 Medical Products, Inc. Files for 3 Patents on Blood Test

for Diagnosis of Early Stage Breast Cancer

signup3m

 

Monday August 31, 2009

************************************************************** Power3 Medical Products, Inc. Files for 3 Patents on Blood Test for Diagnosis of Early Stage Breast Cancer

Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), announced recently that the company made significant advances in the technology for their BC-SeraPro™ serum protein based blood test for diagnosis of early stage breast cancer, as disclosed in recent filings of three pending US utility patent applications.

“Roughly 200,000 women in the US and 1.2 million women

...

PWRM, Power3 Medical Products, Inc. Lourdes R. Bosquez, MD, PA Appointed New Medical Director

Dr. Stock Pick (August 28th, 2009) Writes:

PWRM, Power 3 Medical Products Inc, PWRM.OB

DrStockPick.com News Report!

drstock

Dr Stock Pick HOT News & Alerts!

Power3 Medical Products, Inc. Appoints Medical Director

-Lourdes R. Bosquez, MD, PA Appointed New Medical Director for PWRM-

signup3m

 

Friday August 28, 2009

************************************************************** Power3 Medical Products, Inc. Appoints Medical Director

Lourdes R. Bosquez, MD, PA Appointed New Medical Director for Power3 Medical Products, Inc.

Woodlands, TX, - (CRWENEWSWIRE ) Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), announced that Lourdes R. Bosquez, MD, PA, was appointed Medical Director of the Company.

Power3 Medical Products, Inc., a biotechnology company with diagnostic products for Alzheimer’s disease, Parkinson’s disease, Breast Cancer and other diseases, has secured the

...
Tags for this Post:
281-464-1600, 281-466-1481, ADHD, Biotechnology, bipolar disorder, Breast Cancer, broker, cancer, chief scientific officer, CLIA testing laboratory, Crown Equity Holdings Inc.;, dementia;, Depression, Diagnostic Products, diagnostic tests, director of the company, Dr Stock Pick, equity trader, Helen R. Park;, Houston, Interim CEO, Ira L. Goldknopf, Lourdes R. Bosquez, Market Commentary, Medical Director, Medical Director for its CLIA testing laboratory, member, neurodegenerative disease;, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, Power3’s Scientific Advisory Board, professional investment analyst and consultant, stock featured on our site;, Stock Pick, Stocks to Watch, Texas, The Woodlands, Woodlands;, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.power3medical.com, www.stock-ir.com

PWRM, Power3 Medical Products, Inc. Appoints Medical Director

Dr. Stock Pick (August 27th, 2009) Writes:

PWRM, Power 3 Medical Products Inc, PWRM.OB

DrStockPick.com News Report!

drstock

Dr Stock Pick HOT News & Alerts!

Power3 Medical Products, Inc. Appoints Medical Director

-Lourdes R. Bosquez, MD, PA Appointed New Medical Director for PWRM-

signup3m

 

Thursday August 27, 2009

************************************************************** Power3 Medical Products, Inc. Appoints Medical Director

Lourdes R. Bosquez, MD, PA Appointed New Medical Director for Power3 Medical Products, Inc.

Woodlands, TX, - (CRWENEWSWIRE ) Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), announced that Lourdes R. Bosquez, MD, PA, was appointed Medical Director of the Company.

Power3 Medical Products, Inc., a biotechnology company with diagnostic products for Alzheimer’s disease, Parkinson’s disease, Breast Cancer and other diseases, has secured the

...
Tags for this Post:
281-464-1600, 281-466-1481, ADHD, Biotechnology, bipolar disorder, Breast Cancer, broker, cancer, chief scientific officer, CLIA testing laboratory, Crown Equity Holdings Inc.;, dementia;, Depression, Diagnostic Products, diagnostic tests, director of the company, Dr Stock Pick, equity trader, Helen R. Park;, Houston, Interim CEO, Ira L. Goldknopf, Lourdes R. Bosquez, Market Commentary, Medical Director, Medical Director for its CLIA testing laboratory, member, neurodegenerative disease;, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, Power3’s Scientific Advisory Board, professional investment analyst and consultant, stock featured on our site;, Stock Pick, Stocks to Watch, Texas, The Woodlands, Woodlands;, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.power3medical.com, www.stock-ir.com

DANR, PWRM, NWMT Stock-PR August 26, 2009 Stock Headlines

stock-pr (August 26th, 2009) Writes:

Las Vegas CRWENewswire.com is pleased to announce a stock highlight on Dana Resources (OTC.BB:DANR), Power3 Medical Products, Inc. (OTCBB:PWRM), NewMarket Technology, Inc. (Pinksheets:NWMT)

Dana Resources (OTC.BB:DANR), a US-based precious metals exploration and development company, is pleased to announce the initiation of the production program at its Collota gold deposit. Dana Resources currently owns and operates seven mining projects located in Peru’s most prolific mining regions.

About Dana Resources Dana Resources is a precious and base metals exploration company with offices in the United States and Peru. Dana’s management team possesses local knowledge, extensive international connections, a wealth of experience and technical expertise in mining, mining finance, exploration and production. Dana Resources has acquired a portfolio of gold, silver and other precious & base metal properties located in Peru’s most prolific mining regions. With Peru growing as a producer of gold, silver and other metals on the international market, Dana Resources is well

...
Tags for this Post:
214-722-3065, 281-464-1600, 281-466-1481, ADHD, base metal properties;, Biotechnology, bipolar disorder, Bogota;, Bosquez, Brazil, Breast Cancer, cancer, Chile, China, Cisco Systems, CLIA testing laboratory, Colombia, Crown Equity Holdings Inc.;, CRWENewswire.com, Dana Resources;, dementia;, Depression, Diagnostic Products, diagnostic tests, electronic informative online financial news publication, finance, foreign subsidiary, Helen R. Park;, Houston, I.R.I.S. s.a. TG3Z3510AFCS Headset, industry standard solutions, Infor, Latin America, legacy systems, maintenance services, Market Commentary, Medical Director, Medical Director for its CLIA testing laboratory, member, microsoft, mining, neurodegenerative disease;, NewMarket Colombia, NewMarket Technology Inc., Oracle, Peru, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, producer, prolific mining regions;, registered investment advisor, SAP, SAS, Scientific Advisory Board;, SGD, shanghai, Siebel, Small & Micro Cap, South America, Stock-PR, Sun Microsystems, Technology Assets, technology innovations, Texas, The Woodlands, United States, USD, Venezuela, WBA (Wireless Broadband Access) Telecommunications S.A., www.newmarkettechnology.com

PWRM, Power3 Medical Products, Inc. Appoints Medical Director

Dr. Stock Pick (August 26th, 2009) Writes:

PWRM, Power 3 Medical Products Inc, PWRM.OB

DrStockPick.com News Report!

drstock

Dr Stock Pick HOT News & Alerts!

Power3 Medical Products, Inc. Appoints Medical Director

-Lourdes R. Bosquez, MD, PA Appointed New Medical Director for PWRM-

signup3m

 

Wednesday August 26, 2009

************************************************************** Power3 Medical Products, Inc. Appoints Medical Director

Lourdes R. Bosquez, MD, PA Appointed New Medical Director for Power3 Medical Products, Inc.

Woodlands, TX, - (CRWENEWSWIRE - 08/26/09) Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), today announced that Lourdes R. Bosquez, MD, PA, was appointed Medical Director of the Company.

Power3 Medical Products, Inc., a biotechnology company with diagnostic products for Alzheimer’s disease, Parkinson’s disease, Breast Cancer and other diseases,

...
Tags for this Post:
281-464-1600, 281-466-1481, ADHD, Biotechnology, bipolar disorder, Breast Cancer, broker, cancer, chief scientific officer, CLIA testing laboratory, Crown Equity Holdings Inc.;, dementia;, Depression, Diagnostic Products, diagnostic tests, director of the company, Dr Stock Pick, equity trader, Helen R. Park;, Houston, Interim CEO, Ira L. Goldknopf, Lourdes R. Bosquez, Market Commentary, Medical Director, Medical Director for its CLIA testing laboratory, member, neurodegenerative disease;, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, Power3’s Scientific Advisory Board, professional investment analyst and consultant, stock featured on our site;, Stock Pick, Stocks to Watch, Texas, The Woodlands, Woodlands;, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.power3medical.com, www.stock-ir.com

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.